Pharmacotherapy efficacy assessment in arterial hypertension with metabolic disturbances
Aim. To assess efficacy of various pharmacotherapy schemes in arterial hypertension (AH) with metabolic disturbances (MD). Material and methods. Open, randomized, comparative study in 3 parallel groups, including 90 patients with Stage I-II AH and MD, was performed. Group 1 was administered moxonidi...
Saved in:
| Main Authors: | A. A. Demin, O. M. Medvedeva, I. A. Bondar |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2005-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/942 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01) -
Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01) -
Moxonidine-based combination antihypertensive therapy in patients with metabolic syndrome
by: E. V. Tishina, et al.
Published: (2012-06-01) -
Obesity pharmaceutical correction in metabolic syndrome patients
by: V. B. Mychka, et al.
Published: (2005-08-01) -
Dynamics of lipid profile and circadian pressure rhythms in patients with obesity and arterial hypertension, treated with orlistat and its combination with ACE inhibitors
by: A. G. Avtandilov, et al.
Published: (2005-02-01)